Skip Navigation

About this group

A group for those with Advanced Non-Small Cell Lung Cancer.

Information

  • Public, Open Access
  • All Journey Phases; Non-Small Cell Lung Cancer
  • Advanced Non-Small Cell Lung Cancer (NSCLC)
  • www.navigatingcancer.com

Join Group Members

View all 44 members

Upcoming Events  

There are no upcoming events. Use the links above to add some.
Hi, I'm Polaris75
Hi Larry. I had 28 radiation treatments for prostate cancer. Each treatment took about 15 minutes in and out, and didn’t feel a thing. That was on 205/2016. I also have two kinds of lung cancer in ...
3
  • Sun Jul 8, 2018 · Like1
Hi, I'm Polaris75
Hi. I am also a Vietnam vet who was exposed ty agent orange. I now have three kinds of cancer. Prostate cancer, diagnosed 9/15, squamous cell carcinoma in the upper lobe of my left lung, and adenoc...
4
  • Sun Jul 8, 2018 · Like1
Hi, I'm CYNTHIA S.
I must already have joined. It doesn't give the "join here" when I log in. It does if I'm not logged in. Maybe the person is a member as soon as they post?
45
  • Sun Jul 15, 2018 ·
I'm bettysw, and I'm a survivor of Limited Small Cell Lung Cancer
Hi Gretchen, please keep me posted on any new developments. Remember I am here if you need me. Keep smiling :-) bettysw
5
  • Mon Aug 24, 2015 · Like3
I'm Mary Smith, and I'm a healthcare professional
The National Comprehensive Cancer Network has added guidelines for non-small cell lung cancer patients to their library. The "NCCN Guidelines for Patients":http://www.nccn.com/patient-guidelines.ht...
1
  • Fri Jan 14, 2011 · Like1
Hi, I'm Ned. I've been living with lung cancer since 2006.
The starting times given for the activities on 1/20 and 1/27 are 8:00 p.m. EASTERN Standard Time, which equates to 5:00 p.m. PST, or in my case, 3:00 p.m. HST. Sign up and be there, Aloha! Ned
1
  • Fri Jan 15, 2010 ·
Recommendation
Updated Jan 6, 2010
Video presentation describing the concept behind angiogenesis and the evidence on the anti-angiogenic agent avastin (bevacizumab) in NSCLC.
Recommendation
Updated Jan 6, 2010
One of the core issues in managing advanced NSCLC is second line chemotherapy, which was established as improving survival several years ago. This video presentation provides a brief summary of th... more
Recommendation
Updated Jan 6, 2010
An interview with Dr. Suresh Ramalingam, medical oncologist and Director of the Thoracic Oncology Program at Winship Cancer Institute at Emory University. It covers the current status of initial t... more
Recommendation
Updated Jan 6, 2010
Dr. Sandler recently moved from Vanderbilt to Oregon Health & Science University in Portland where he leads the Division of Hematology and Oncology. He was kind enough to participate in GRACE's N... more
Recommendation
Updated Jan 6, 2010
Dr. George Simon, medical oncologist and Director of the Thoracic Oncology Program at Fox Chase Cancer Center in Philadelphia speaks about molecular factors that are emerging to help us individuali... more